REPLIGEN CORPORATION - COMMON STOCK
122.32
29-May-25 13:45:00
15 minutes delayed
Stocks
+1.14
+0.94%
Today's range
120.96 - 123.71
ISIN
N/A
Source
NASDAQ
-
Repligen Reports Second Quarter 2024 Financial Results
30 Jul 2024 04:30:01 By Nasdaq GlobeNewswire
-
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
29 Jul 2024 13:00:00 By Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2024 Financial Results
16 Jul 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Announces CEO Transition Plan
13 Jun 2024 04:00:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming June Investor Conferences
22 May 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming May Investor Conferences
07 May 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2024 Financial Results
01 May 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2024 Financial Results
17 Apr 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Maggie A. Pax to Board of Directors
19 Mar 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 04:30:01 By Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results
07 Feb 2024 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 04:30:00 By Nasdaq GlobeNewswire
-
07 Dec 2023 04:30:00 By Nasdaq GlobeNewswire
-
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
14 Nov 2023 11:01:50 By Nasdaq GlobeNewswire
-
Repligen Announces Publication of the Company’s 2022 Sustainability Report
14 Nov 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
07 Nov 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
02 Nov 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
31 Oct 2023 04:30:01 By Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2023 Financial Results
17 Oct 2023 04:30:00 By Nasdaq GlobeNewswire
-
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
02 Oct 2023 04:30:00 By Nasdaq GlobeNewswire